[{"address1": "One Amgen Center Drive", "city": "Thousand Oaks", "state": "CA", "zip": "91320-1799", "country": "United States", "phone": "805 447 1000", "fax": "805 447 1010", "website": "https://www.amgen.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Beh\u00e7et's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert A. Bradway", "age": 62, "title": "Chairman & CEO", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 6428574, "exercisedValue": 0, "unexercisedValue": 50993104}, {"maxAge": 1, "name": "Mr. Peter H. Griffith", "age": 66, "title": "Executive VP & CFO", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 3007214, "exercisedValue": 0, "unexercisedValue": 1401880}, {"maxAge": 1, "name": "Dr. David M. Reese M.D.", "age": 62, "title": "Executive VP & CTO", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 3327225, "exercisedValue": 0, "unexercisedValue": 7193319}, {"maxAge": 1, "name": "Mr. Murdo  Gordon", "age": 58, "title": "Executive Vice President of Global Commercial Operations", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 3174030, "exercisedValue": 0, "unexercisedValue": 4835902}, {"maxAge": 1, "name": "Dr. James E. Bradner M.D.", "age": 53, "title": "Executive Vice President of Research & Development", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 4095677, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Esteban  Santos", "age": 57, "title": "Executive Vice President of Operations", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 3006074, "exercisedValue": 0, "unexercisedValue": 12988893}, {"maxAge": 1, "name": "Mr. Matthew C. Busch", "age": 50, "title": "Chief Accounting Officer & VP of Finance", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Skellenger", "title": "Senior VP & Chief Information Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Howard Y. Chang M.D., Ph.D.", "title": "Senior VP of Global Research & Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Casey  Capparelli", "title": "Executive Director of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 8, "compensationRisk": 4, "shareHolderRightsRisk": 2, "overallRisk": 3, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-IRHome", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 363.68, "open": 362.1, "dayLow": 361.71, "dayHigh": 370.42, "regularMarketPreviousClose": 363.68, "regularMarketOpen": 362.1, "regularMarketDayLow": 361.71, "regularMarketDayHigh": 370.42, "dividendRate": 9.66, "dividendYield": 2.62, "exDividendDate": 1770940800, "payoutRatio": 0.669, "fiveYearAvgDividendYield": 3.07, "beta": 0.472, "trailingPE": 25.980999, "forwardPE": 15.964518, "volume": 2413599, "regularMarketVolume": 2413599, "averageVolume": 2931723, "averageVolume10days": 3378010, "averageDailyVolume10Day": 3378010, "bid": 368.72, "ask": 369.35, "bidSize": 2, "askSize": 2, "marketCap": 198993412096, "fiftyTwoWeekLow": 261.43, "fiftyTwoWeekHigh": 385.12, "allTimeHigh": 385.12, "allTimeLow": 0.075521, "priceToSalesTrailing12Months": 5.4146395, "fiftyDayAverage": 337.3922, "twoHundredDayAverage": 304.71634, "trailingAnnualDividendRate": 9.52, "trailingAnnualDividendYield": 0.02617686, "currency": "USD", "tradeable": false, "enterpriseValue": 244468416512, "profitMargins": 0.20982, "floatShares": 537614770, "sharesOutstanding": 539000000, "sharesShort": 13263244, "sharesShortPriorMonth": 14978144, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.024600001, "heldPercentInsiders": 0.00212, "heldPercentInstitutions": 0.84809995, "shortRatio": 5.06, "shortPercentOfFloat": 0.0247, "impliedSharesOutstanding": 539000000, "bookValue": 16.063, "priceToBook": 22.983877, "lastFiscalYearEnd": 1767139200, "nextFiscalYearEnd": 1798675200, "mostRecentQuarter": 1767139200, "earningsQuarterlyGrowth": 1.126, "netIncomeToCommon": 7711000064, "trailingEps": 14.21, "forwardEps": 23.12566, "lastSplitFactor": "2:1", "lastSplitDate": 943228800, "enterpriseToRevenue": 6.652, "enterpriseToEbitda": 14.327, "52WeekChange": 0.25068307, "SandP52WeekChange": 0.11471915, "lastDividendValue": 2.52, "lastDividendDate": 1770940800, "quoteType": "EQUITY", "currentPrice": 369.19, "targetHighPrice": 425.0, "targetLowPrice": 180.0, "targetMeanPrice": 345.55557, "targetMedianPrice": 350.0, "recommendationMean": 2.46875, "recommendationKey": "buy", "numberOfAnalystOpinions": 27, "totalCash": 9128999936, "totalCashPerShare": 16.937, "ebitda": 17063999488, "totalDebt": 54604001280, "quickRatio": 0.734, "currentRatio": 1.14, "totalRevenue": 36750999552, "debtToEquity": 630.677, "revenuePerShare": 68.31, "returnOnAssets": 0.081520006, "returnOnEquity": 1.0610299, "grossProfits": 26013999104, "freeCashflow": 7599750144, "operatingCashflow": 9957999616, "earningsGrowth": 1.116, "revenueGrowth": 0.086, "grossMargins": 0.70783997, "ebitdaMargins": 0.46431, "operatingMargins": 0.28218, "financialCurrency": "USD", "symbol": "AMGN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 424704600000, "exchange": "NMS", "messageBoardId": "finmb_24816", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.51507, "regularMarketPrice": 369.19, "postMarketChangePercent": -0.27175596, "postMarketPrice": 368.1867, "postMarketChange": -1.0032959, "regularMarketChange": 5.51001, "regularMarketDayRange": "361.71 - 370.42", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2931723, "fiftyTwoWeekLowChange": 107.76001, "fiftyTwoWeekLowChangePercent": 0.41219452, "fiftyTwoWeekRange": "261.43 - 385.12", "fiftyTwoWeekHighChange": -15.929993, "fiftyTwoWeekHighChangePercent": -0.041363712, "fiftyTwoWeekChangePercent": 25.068306, "dividendDate": 1772755200, "earningsTimestamp": 1770152400, "corporateActions": [], "postMarketTime": 1771030243, "regularMarketTime": 1771016402, "shortName": "Amgen Inc.", "longName": "Amgen Inc.", "earningsTimestampStart": 1777582800, "earningsTimestampEnd": 1777582800, "earningsCallTimestampStart": 1770154200, "earningsCallTimestampEnd": 1770154200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 14.21, "epsForward": 23.12566, "epsCurrentYear": 22.36544, "priceEpsCurrentYear": 16.507164, "fiftyDayAverageChange": 31.79779, "fiftyDayAverageChangePercent": 0.09424578, "twoHundredDayAverageChange": 64.47366, "twoHundredDayAverageChangePercent": 0.21158585, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.5 - Buy", "cryptoTradeable": false, "displayName": "Amgen", "trailingPegRatio": 1.1267, "__fetch_time": "2026-02-14"}]